Top brokers pick the latest ASX shares to buy today

The bulls are back! The S&P/ASX 200 Index (Index:^AXJO) jumped to a 12-week high and there are still good value stocks to be found.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The bulls are back! The S&P/ASX 200 Index (Index:^AXJO) jumped a further 1.3% on Thursday – pushing the benchmark to a 12 week high.

We are likely to see more gains in the short-term too despite the market's 29% gain since it hit a bear market bottom in late March.

More room for bulls to run

There are a few reasons for this, including an expected string of positive data from the gradual reopening of the global economy after the COVID-19 shutdown.

ASX shares certainly aren't as cheap as they were in recent past, but there's still value to be found for those who are yet to join in the party.

Testing positive in a good way

Testing and certification services provider ALS Ltd (ASX: ALQ) is one that makes the cut, according to Morgans.

The broker reiterated it's "add" recommendation on the stock after management posted its full year results yesterday.

"FY20 underlying financials met guidance despite COVID headwinds in Feb-Mar, suggesting Life Sciences [business] was tracking ahead of our expectations," said the broker.

"We think the stock can keep running in-line with the re-opening of the global economy, and as it approaches the late July AGM where a critical trading update will be provided."

The 6.1 cents a share dividend was also a positive surprise, although that was offset by a $90 million write-down of some underperforming businesses.

However, Morgans thinks the FY21 outlook for ALS is looking relatively bright considering the uncertainty caused by COVID-19.

The broker's target price on the stock is $8.28 a share.

Strength in numbers

Meanwhile, JP Morgan reiterated its "overweight" rating on TPG Telecom Ltd (ASX: TPM) today as it believes there is good revenue upside potential for the telco post its merger with Vodafone Australia.

"There are a variety of revenue synergies that the company can pursue as a result of the merger and all are additive, with some potentially yielding as much as 30% further upside on a standalone basis," said the broker.

These opportunities include fixed wireless broadband solution, fixed wireless data offload (used to cover holes in NBN coverage), cross selling NBN to Vodafone customers and cross selling mobile to TPG's customers.

"While we currently don't incorporate any of these opportunities in our estimates, adding them all together yields up to 85% further potential upside to our current DCF valuation," added JP Morgan.

The broker's current price target on the stock is $8.65 a share.

Motley Fool contributor Brendon Lau owns shares of TPG Telecom Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Cheap Shares

These ASX 200 shares are down 40% to 65% and could be bargain buys

It could be a good move buying the dip on these big-name shares.

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Cheap Shares

3 cheap ASX shares that could be hiding in plain sight

Here's why now could be an opportune time to buy these fallen giants.

Read more »

Boy dressed in business suit with rocket strapped to back ready to take off
Cheap Shares

2 ASX shares tipped to grow 50% or more in the next 12 months

Analysts love the potential of these stocks!

Read more »

Red buy button on an Apple keyboard with a finger on it.
Cheap Shares

2 ASX shares highly recommended to buy: Experts

Analysts really like these stocks!

Read more »

Frustrated and shocked businesswoman reading bad news online from phone.
Cheap Shares

Down 65%+, why I'd buy and hold these ASX shares

These ASX shares are not low-risk, but I think they could be worth buying and holding for patient investors.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Cheap Shares

A rare buying opportunity in 1 of Australia's top shares?

Here’s why I think it’s a strong long-term buy…

Read more »

Buy and sell keys on an Apple keyboard.
Cheap Shares

2 ASX shares highly recommended to buy: Experts

Many experts like these ASX shares. Here’s why…

Read more »

patient with doctor, medical company, medical insurance
Cheap Shares

CSL shares trade at just 12 times forecast earnings. Here's why they could be the buy of the decade

The ASX 200 healthcare giant is down more than 60% since August 2025.

Read more »